A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma
Clinical trial NCT02975700 · COMPLETED
Trial details
- NCT number
- NCT02975700
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-31
- Primary completion
- 2018-08-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.